Clinical trial
D-cycloserine: A Novel Treatment for Gulf War Illness
NCT02983734 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- D-cycloserine: A Novel Treatment for Gulf War Illness
- Lead sponsor
- Boston University Charles River Campus
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- September 15, 2019
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gulf war illness